Ernexa Therapeutics Inc. Made Big Gain
Fri, May 15, 2026 at 07:36 PM
Ernexa Therapeutics Inc. (ERNA:NASDAQ) jumped higher at $13.63, a gain of 42.6%. On Fri, May 15, 2026, ERNA:NASDAQ hit a New 2-Week High of $13.63. The stock got featured on our News Catalysts scanner on Mon, May 11, 2026 at 12:11 PM in the 'BIOTECH' category. From Fri, May 01, 2026, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Tue, May 12, 2026 at $15.88 with a volume of 19M+.
About Ernexa Therapeutics Inc. (ERNA:NASDAQ)
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer.
Top 10 Gainers:
- HCW Biologics Inc. (HCWB:NASDAQ), 262.02%
- P3 Health Partners Inc. (PIII:NASDAQ), 179.83%
- Murano Global Investments Plc (MRNO:NASDAQ), 94.24%
- Auddia Inc. (AUUD:NASDAQ), 60.66%
- Super League Enterprise, Inc. (SLE:NASDAQ), 51.57%
- Trio-Tech International (TRT:NYSEMKT), 43.01%
- Ernexa Therapeutics Inc. (ERNA:NASDAQ), 42.57%
- SKK Holdings Limited (SKK:NASDAQ), 40.71%
- Smart for Life, Inc. (SMFL:NASDAQ), 33.33%
- RoboStrategy Inc. (BOT:NASDAQ), 32.88%